Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth A Abels

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
JAMA|February 6, 2024
Rh Sensitization and Induced AbortionKenneth J Moise, Elizabeth A Abels
Obstetrics and Gynecology|August 15, 2024
Management of Red Cell Alloimmunization in PregnancyKenneth J Moise, Elizabeth A Abels
British Journal of Haematology|July 11, 2023
Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newbornJeremy W Jacobs, Jia Jennifer Ding, Christopher A Tormey, et al.
American Journal of Hematology|December 31, 2025
Factor XIII Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical ImplementationJeremy W Jacobs, Elizabeth A Abels, Brian D Adkins, et al.
Transfusion|September 9, 2024
Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United StatesJeremy W Jacobs, Garrett S Booth, Kenneth J Moise, et al.
Transfusion Medicine Reviews|April 20, 2025
The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test AccuracyJeremy W Jacobs, Ronan P Sugrue, Jerome Jeffrey Federspiel, et al.
American Journal of Hematology|September 26, 2024
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W Jacobs, Garrett S Booth, Sheharyar Raza, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
JAMA|February 6, 2024
Rh Sensitization and Induced AbortionKenneth J Moise, Elizabeth A Abels
Obstetrics and Gynecology|August 15, 2024
Management of Red Cell Alloimmunization in PregnancyKenneth J Moise, Elizabeth A Abels
British Journal of Haematology|July 11, 2023
Where do they go? The clinical conundrum of warm autoantibodies and their inability to cause haemolytic disease of the foetus and newbornJeremy W Jacobs, Jia Jennifer Ding, Christopher A Tormey, et al.
American Journal of Hematology|December 31, 2025
Factor XIII Supplementation in Postpartum Hemorrhage: From Biological Rationale to Clinical ImplementationJeremy W Jacobs, Elizabeth A Abels, Brian D Adkins, et al.
Transfusion|September 9, 2024
Characterization of blood bank and transfusion medicine practices for pregnant individuals with fetuses at risk of hemolytic disease in the United StatesJeremy W Jacobs, Garrett S Booth, Kenneth J Moise, et al.
Transfusion Medicine Reviews|April 20, 2025
The Utility of a Critical Antibody Titer in Anti-K Alloimmunized Pregnancies: A Systematic Review and Meta-Analysis of Diagnostic Test AccuracyJeremy W Jacobs, Ronan P Sugrue, Jerome Jeffrey Federspiel, et al.
American Journal of Hematology|September 26, 2024
Current state and potential applications of neonatal Fc receptor (FcRn) inhibitors in hematologic conditionsJeremy W Jacobs, Garrett S Booth, Sheharyar Raza, et al.
Pageof 1